DIVINHEALSimplifying Global Wellbeing
Home
Treatments
Hospitals
Doctors
Page background

About

Targeted Molecular Therapy in New Delhi for Bangladesh Patients | Costs, Hospitals

Patients from Bangladesh considering advanced medical care often face a significant decision, especially when a diagnosis requires specialized treatment like Targeted Molecular Therapy. The uncertainty around finding the right expertise, navigating a new healthcare system, and managing treatment costs can feel overwhelming.

Many families look beyond their borders for effective solutions, and New Delhi stands out as a leading medical destination. This city offers a concentration of world-class hospitals and a supportive environment for international patients. Its established infrastructure ensures a seamless treatment journey.

New Delhi’s medical community has earned trust through consistent high-quality care, particularly in oncology and advanced therapies. Patients can access highly skilled specialists and state-of-the-art facilities. This makes follow-ups and comprehensive care manageable within the city.

Exploring Targeted Molecular Therapy in New Delhi offers a path to specialized, high-quality healthcare.

What is Targeted Molecular Therapy?

Targeted Molecular Therapy is a type of cancer treatment that uses drugs to specifically identify and attack cancer cells while minimizing harm to normal cells. Unlike traditional chemotherapy, which acts broadly on fast-growing cells, targeted therapy works by interfering with specific molecules involved in cancer cell growth, progression, and spread. These molecules are often unique to cancer cells or are overactive in them. The therapy focuses on blocking these specific pathways, leading to more precise and often less toxic treatment outcomes.

Classes of Targeted Molecular Therapies

Targeted Molecular Therapies are categorized based on their mechanism of action and the specific targets they address:

  • Kinase Inhibitors: These drugs block the activity of enzymes called kinases, which are crucial for cell growth and division. Many cancers rely on overactive kinases.
  • Monoclonal Antibodies: These are laboratory-produced molecules engineered to mimic the immune system’s antibodies. They attach to specific targets on cancer cells, marking them for destruction or blocking signals they need to grow.
  • Angiogenesis Inhibitors: These therapies prevent the formation of new blood vessels that tumors need to grow and spread. By cutting off the blood supply, the tumor is starved.
  • PARP Inhibitors: These drugs block poly-ADP ribose polymerase (PARP) enzymes, which help repair damaged DNA in cells. By inhibiting PARP, cancer cells with certain genetic mutations struggle to repair their DNA, leading to cell death.
  • Immunotherapies (Checkpoint Inhibitors): While often considered a separate class, some immunotherapies specifically target molecular pathways that cancer cells use to evade the immune system, effectively unmasking them for immune attack.

When is Targeted Molecular Therapy Recommended?

  • When specific genetic mutations or protein overexpression are identified in cancer cells (e.g., EGFR, HER2, ALK, BRAF mutations).
  • For various types of cancer, including certain lung cancers, breast cancers, colon cancers, melanomas, leukemias, and lymphomas.
  • When standard chemotherapy has been ineffective or is not suitable due to severe side effects or patient health.
  • As a frontline treatment for certain cancers, especially those with known targetable mutations.
  • To reduce tumor size before surgery or radiation therapy.
  • To prevent cancer recurrence in high-risk patients.
  • In cases of metastatic cancer to control disease progression and improve quality of life.

Pre-Treatment Evaluation for Targeted Molecular Therapy

  • Biopsy and Tumor Tissue Analysis: To identify specific genetic mutations, protein expression, or other biomarkers that can be targeted by therapy. This often involves advanced molecular profiling.
  • Blood Tests: Complete blood count, liver and kidney function tests, and other markers to assess overall health and organ function.
  • Imaging Scans: CT, MRI, PET scans to determine the extent of the cancer, identify metastatic sites, and monitor tumor response.
  • Cardiac Evaluation: Electrocardiogram (ECG) and echocardiogram may be required, as some targeted therapies can affect heart function.
  • Genetic Counseling: To understand the implications of identified mutations for treatment and potential hereditary risks.
  • Overall Health Assessment: A thorough physical examination and medical history review by an oncologist.

How Targeted Molecular Therapy is Performed

The specific method of administering Targeted Molecular Therapy depends on the type of drug, the patient’s condition, and the treatment plan.

Oral Medication

Many targeted therapy drugs are available in pill form and can be taken orally at home. Patients receive detailed instructions on dosage, timing, and potential side effects. Regular follow-up appointments and blood tests are crucial to monitor progress and manage any adverse reactions.

Intravenous Infusion

Some targeted therapies, particularly monoclonal antibodies, are administered intravenously (IV), meaning they are given directly into a vein. These infusions typically take place in a hospital or clinic setting and can last from 30 minutes to several hours. The frequency of infusions varies, often ranging from weekly to every few weeks, as determined by the oncologist.

Treatment Cycles

Targeted therapy is usually given in cycles, with periods of treatment followed by rest periods. This allows the body to recover and helps manage side effects. The duration of treatment can range from several months to years, depending on the disease response and patient tolerance. Continuous monitoring for efficacy and side effects is a cornerstone of this therapy.

Recovery Process After Targeted Molecular Therapy

Recovery from Targeted Molecular Therapy is often different from traditional chemotherapy. While side effects can occur, they are generally less severe and more specific, often including skin rashes, fatigue, diarrhea, or blood pressure changes. Patients typically experience an improved quality of life compared to conventional treatments. Regular follow-up visits with the oncology team are essential to monitor treatment effectiveness, manage side effects, and adjust the regimen if necessary. Long-term surveillance, including imaging and blood tests, helps track disease status and detect any recurrence or progression, ensuring sustained care and support.

Risks and Success Rates of Targeted Molecular Therapy

  • Skin Reactions: Rashes, dry skin, nail changes are common, particularly with certain types of targeted agents.
  • Gastrointestinal Issues: Diarrhea, nausea, or abdominal discomfort can occur.
  • Fatigue: A general feeling of tiredness is a frequent side effect.
  • Cardiovascular Effects: Some therapies may affect heart function or blood pressure, requiring careful monitoring.
  • Liver or Kidney Toxicity: Less common, but can occur, necessitating regular blood tests.
  • Immune Reactions: In rare cases, severe allergic or immune-related reactions can develop.
  • Acquired Resistance: Cancer cells can sometimes adapt and develop resistance to targeted therapies over time.

The success rates of Targeted Molecular Therapy vary significantly based on the specific cancer type, the identified genetic mutations, the stage of the disease, and individual patient factors. For some cancers, targeted therapies have dramatically improved outcomes, leading to longer progression-free survival and overall survival rates. While complete cures are not always achieved, these therapies can often stabilize disease, reduce tumor size, and extend life with a better quality of life. Results depend on how well the therapy targets the specific cancer pathway and the patient's overall response to the medication.

Considering Targeted Therapy?

Connect with New Delhi's top oncologists for a personalized consultation. Our team can help you understand your options and next steps.

Cost of Targeted Molecular Therapy in New Delhi

The cost of Targeted Molecular Therapy in New Delhi depends on several factors. These include the specific type of targeted drug used, the duration of treatment, the hospital chosen, and any additional diagnostic tests or supportive care required. The brand of medication, whether it is an oral drug or an IV infusion, and the frequency of administration all play a role in the total expense.

For a typical course of Targeted Molecular Therapy, patients can expect costs to range from approximately INR 5,00,000 to INR 25,00,000 or more per cycle or for a defined duration, depending on the specific drug protocol.

New Delhi vs. Global Targeted Molecular Therapy Costs

New Delhi offers a competitive pricing structure for advanced medical treatments like Targeted Molecular Therapy, providing significant cost advantages compared to many Western countries while maintaining high standards of care.

Location Estimated Cost Range (USD)
New Delhi, India $6,000 - $30,000+ (per cycle/duration)
United States $30,000 - $100,000+ (per cycle/duration)
United Kingdom $20,000 - $70,000+ (per cycle/duration)
Singapore $15,000 - $50,000+ (per cycle/duration)
Thailand $8,000 - $35,000+ (per cycle/duration)

Comprehensive Support Services for Your Treatment in New Delhi

  • Detailed medical opinion and treatment plan from leading New Delhi oncologists.
  • Assistance with medical visa applications and travel arrangements to New Delhi.
  • Dedicated patient coordinator to guide you through your entire journey.
  • Arrangement of comfortable accommodation close to your chosen hospital.
  • Translation services during consultations and hospital stays.
  • Logistical support for local transport and appointments.
  • Post-treatment follow-up coordination and remote care options.

Essential Documents for Your Medical Visit to New Delhi

  • Current passport with at least six months validity.
  • Valid medical visa for India (or e-visa, if applicable).
  • Comprehensive medical history, including previous diagnoses, treatment records, and pathology reports.
  • Recent lab results, imaging scans (CT, MRI, PET), and biopsy reports.
  • List of all current medications, including dosages.
  • Contact information for your primary care physician back home.
  • Proof of financial capacity for treatment and travel expenses.

Preparing for Your Targeted Therapy in New Delhi

  • Undergo all recommended pre-travel health check-ups and vaccinations.
  • Organize your medical records and ensure they are translated into English.
  • Confirm travel dates and accommodation arrangements in New Delhi.
  • Pack comfortable clothing and any personal items for your stay.
  • Arrange for a companion or family member to travel with you, if possible.
  • Understand your treatment plan and expected duration from your oncologist.
  • Inform your home doctor about your plans for international treatment.

Recovery and Post-Treatment Care After Targeted Therapy

  • Adhere strictly to your oncologist's instructions regarding medication and follow-up.
  • Monitor for any new or worsening side effects and report them promptly.
  • Maintain a healthy diet and lifestyle as advised by your medical team.
  • Schedule regular follow-up appointments and diagnostic tests in New Delhi or remotely.
  • Understand the signs and symptoms that require immediate medical attention.
  • Plan for a comfortable and safe journey back to Bangladesh after clearance from your doctor.
  • Maintain open communication with your New Delhi care team for ongoing support.

Ready to Explore Targeted Molecular Therapy?

Our patient support team is available to answer your questions and help you plan your treatment journey to New Delhi. Reach out today.

Empowering Your Health Journey with Expert Care

Making informed decisions about advanced medical treatment is vital. New Delhi offers world-class Targeted Molecular Therapy, supported by experienced specialists and comprehensive patient care systems, guiding you towards better health outcomes.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Noaline Sinha

Dr. Noaline Sinha

Chairperson - Nuclear Medicine & Radio-Theranostics

Nuclear Medicine

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Shelly Mittal

Dr. Shelly Mittal

Sr. Consultant

Medical Oncology & Hematology

New Delhi

14+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Shubhra Shri Gupta

Dr. Shubhra Shri Gupta

Sr. Consultant

Medical Oncology & Hemato Oncology

New Delhi

9+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Prasun Chatterjee

Dr. Prasun Chatterjee

Director - Medical Oncology

Medical Oncology

New Delhi

17+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Anshuman Manaswi

Dr. Anshuman Manaswi

Senior Consultant Plastic Surgeon

Plastic Surgery

New Delhi

19+ Years

Experience

Max Hospital,Gurgaon

Hospital

1500

Fees

View Details
Dr. Pramod Kumar Julka

Dr. Pramod Kumar Julka

Senior Oncologist, Max Healthcare; Former Dean & Professor, AIIMS

Cancer Care & Oncology

New Delhi

15+ Years

Experience

Max Hospital,Gurgaon

Hospital

1500

Fees

View Details
Dr. Pankaj Dougall

Dr. Pankaj Dougall

Principal Director & Head – Nuclear Medicine

Nuclear Medicine

New Delhi

38+ Years

Experience

Max Hospital,Gurgaon

Hospital

1500

Fees

View Details
Dr. Sushil Gupta

Dr. Sushil Gupta

Director, Medical Oncology

Medical Oncology

New Delhi

30+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. H S Bhatyal

Dr. H S Bhatyal

Director

Medical Oncology

New Delhi

44+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. C.P.S. Chauhan

Dr. C.P.S. Chauhan

Principal Director & Chief of Medical Oncology

Medical Oncology

New Delhi

30+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Naresh Aggarwal

Dr. Naresh Aggarwal

Sr. Consultant

Medical Oncology

New Delhi

29+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Nikhil Agrawal

Dr. Nikhil Agrawal

Director - Medical Oncology

Medical Oncology

New Delhi

20+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Hari Goyal

Dr. Hari Goyal

Director

Medical Oncology & Haemato-Oncology

New Delhi

34+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Alok Gupta

Dr. Alok Gupta

Director

Oncology

New Delhi

26+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Vijay Kumar

Dr. Vijay Kumar

Director & Head

Medical Oncology & Haematology

New Delhi

20+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dodul Mondal

Dodul Mondal

Sr. Consultant

Medical & Haemato Oncology

New Delhi

8+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Manik Sharma

Dr. Manik Sharma

Director

Medical Oncology

New Delhi

13+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Ivan Singh

Dr. Ivan Singh

Director - Medical Oncology

Medical Oncology

New Delhi

13+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details

Related Links

क्या आप अपनी चिकित्सा यात्रा शुरू करने के लिए तैयार हैं?

भारत के शीर्ष अस्पतालों से व्यक्तिगत चिकित्सा उपचार विकल्प प्राप्त करें। हमारे चिकित्सा विशेषज्ञ हर कदम पर आपकी सहायता करने के लिए तैयार हैं।